Market Price

8.60 

0.24 2.9%

as of Mar 20 '23

52 Week Range:

8.32 37.73


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers sterile transfer systems, closure processing systems, washers, isolators, sterilizers, logistic automation solutions, bioreactors, bioprocess control systems, bioprocess software, biobundles, bioprocess analytics, and perfusion systems; practice-oriented monitoring systems and disposables, anesthesia machines, beating heart stabilizers and positioners, axius blower mister and coronary shunts, proximal seal systems, ceiling supply units, connected solutions, cleaning and disinfection products, packaging and sealing solutions, monitors and indicators, and SteriTec products. The company also provides thoracic catheters, dry seal chest drain, mobile dry seal drain, dry and wet suction water seal chest drain, and chest drain valves; transitional accessories; endoscope reprocessing; endoscopic vessel harvesting systems; endovascular products; extracorporeal life support or extracorporeal membrane oxygenation products; inspection and packing products; intra-aortic balloon counter pulsation therapies; mechanical ventilation products; medical furniture; modular room systems; operating lights and tables; OR integration and management; patient flow management; patient transport; sterile supply management; sterilization; surgical assist systems; surgical perfusion; transport & storage; trays & baskets; and vascular and cardiothoracic surgery solutions. It offers its products through a network of proprietary sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Equity (BVPS) 6.33
6.67
6.74
6.96
7.99
7.78
8.70
6.58
7.18
7.86
8.45
growth rate 5.4% 1.1% 3.3% 14.8% -2.6% 11.8% -24.4% 9.1% 9.5% 7.5%
Earnings BIT 4,395.00
3,928.00
3,638.00
2,731.00
2,359.00
-116.00
2,689.00
5,008.00
4,266.00
growth rate -10.6% -7.4% -24.9% -13.6% -100.0% 100.0% 86.2% -14.8%
Avg.PE 27.63
27.26
15.63
12.51
12.51
12.51
12.51
growth rate -1.3% -42.7% -20.0% 0.0% 0.0% 0.0%
ROA 6.65
5.97
5.24
2.95
2.62
2.19
2.83
-2.26
2.78
7.22
6.63
growth rate -10.2% -12.2% -43.7% -11.2% -16.4% 29.2% -100.0% 100.0% 159.7% -8.2%
ROE 18.17
16.93
14.42
8.22
7.40
5.98
6.90
-5.01
6.16
15.60
12.98
growth rate -6.8% -14.8% -43.0% -10.0% -19.2% 15.4% -100.0% 100.0% 153.3% -16.8%
ROIC 10.08
9.09
8.11
5.20
4.77
3.94
4.85
-2.17
4.92
11.07
10.19
growth rate -9.8% -10.8% -35.9% -8.3% -17.4% 23.1% -100.0% 100.0% 125.0% -8.0%
Cur. Ratio 1.70
1.31
1.40
1.11
1.29
1.28
1.19
1.41
1.47
1.78
1.42
growth rate -22.9% 6.9% -20.7% 16.2% -0.8% -7.0% 18.5% 4.3% 21.1% -20.2%
Quick Ratio 1.07
0.87
0.91
0.67
0.81
0.84
0.75
0.90
0.94
1.29
0.95
growth rate -18.7% 4.6% -26.4% 20.9% 3.7% -10.7% 20.0% 4.4% 37.2% -26.4%
Leverage 2.84
2.83
2.68
2.88
2.77
2.69
2.17
2.26
2.18
2.14
1.80
growth rate -0.4% -5.3% 7.5% -3.8% -2.9% -19.3% 4.2% -3.5% -1.8% -15.9%
Balance Sheet Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Acct.Receivable 7,127.00
7,891.00
8,902.00
9,498.00
10,219.00
7,929.00
8,238.00
8,445.00
6,759.00
6,038.00
growth rate 10.7% 12.8% 6.7% 7.6% -22.4% 3.9% 2.5% -20.0% -10.7%
Acct.Payable 1,906.00
1,882.00
2,083.00
1,986.00
2,201.00
2,025.00
1,868.00
1,995.00
1,446.00
1,921.00
growth rate -1.3% 10.7% -4.7% 10.8% -8.0% -7.8% 6.8% -27.5% 32.9%
Cur.Assets 13,073.00
14,169.00
16,373.00
16,619.00
17,565.00
14,560.00
14,148.00
14,494.00
17,431.00
15,069.00
growth rate 8.4% 15.6% 1.5% 5.7% -17.1% -2.8% 2.5% 20.3% -13.6%
Total Assets 42,921.00
44,303.00
52,818.00
53,235.00
55,211.00
42,102.00
43,352.00
44,713.00
45,014.00
44,555.00
growth rate 3.2% 19.2% 0.8% 3.7% -23.7% 3.0% 3.1% 0.7% -1.0%
Cash 1,254.00
1,148.00
1,482.00
1,468.00
1,680.00
1,526.00
1,273.00
1,254.00
6,056.00
4,076.00
growth rate -8.5% 29.1% -0.9% 14.4% -9.2% -16.6% -1.5% 382.9% -32.7%
Inventory 4,060.00
4,254.00
5,245.00
5,409.00
5,431.00
4,879.00
4,544.00
4,691.00
4,513.00
4,767.00
growth rate 4.8% 23.3% 3.1% 0.4% -10.2% -6.9% 3.2% -3.8% 5.6%
Cur.Liabilities 10,003.00
10,140.00
14,744.00
12,739.00
13,669.00
12,268.00
10,005.00
9,864.00
9,788.00
10,610.00
growth rate 1.4% 45.4% -13.6% 7.3% -10.3% -18.5% -1.4% -0.8% 8.4%
Liabilities 27,721.00
27,743.00
34,124.00
33,642.00
34,295.00
22,296.00
23,697.00
23,740.00
23,528.00
19,378.00
growth rate 0.1% 23.0% -1.4% 1.9% -35.0% 6.3% 0.2% -0.9% -17.6%
LT Debt 13,146.00
13,555.00
14,368.00
16,006.00
15,914.00
4,962.00
7,459.00
6,487.00
7,034.00
2,795.00
growth rate 3.1% 6.0% 11.4% -0.6% -68.8% 50.3% -13.0% 8.4% -60.3%
Equity 18,342.00
19,203.00
20,508.00
19,384.00
19,201.00
20,496.00
21,024.00
24,750.00
growth rate 4.7% 6.8% -5.5% -0.9% 6.7% 2.6% 17.7%
Common Shares 253.00
253.00
253.00
253.00
253.00
242.00
251.00
136.00
136.00
136.00
136.00
growth rate 0.0% 0.0% 0.0% 0.0% -4.4% 3.7% -45.8% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Capital Expenditures 1,255.00
1,303.00
1,166.00
1,352.00
688.00
811.00
555.00
385.00
437.00
462.00
growth rate 3.8% -10.5% 16.0% -49.1% 17.9% -31.6% -30.6% 13.5% 5.7%
Cash Dividends 989.00
667.00
667.00
477.00
409.00
272.00
409.00
817.00
growth rate -32.6% 0.0% -28.5% -14.3% -33.5% 50.4% 99.8%
Cash From OA 3,687.00
3,544.00
3,473.00
3,458.00
3,671.00
2,763.00
2,503.00
3,832.00
7,199.00
6,560.00
growth rate -3.9% -2.0% -0.4% 6.2% -24.7% -9.4% 53.1% 87.9% -8.9%
FCF per Share 0.89
0.96
0.83
0.73
1.80
0.58
0.82
0.51
0.56
1.91
2.36
growth rate 7.9% -13.5% -12.1% 146.6% -67.8% 41.4% -37.8% 9.8% 241.1% 23.6%
Sale Purchase of Stock 4,281.00
4,281.00
4,281.00
4,281.00
growth rate 0.0% 0.0% 0.0%
FCF 2,237.00
1,983.00
1,861.00
2,800.00
1,710.00
2,246.00
1,100.00
1,123.00
2,612.00
6,154.00
5,630.00
growth rate -11.4% -6.2% 50.5% -38.9% 31.4% -51.0% 2.1% 132.6% 135.6% -8.5%
Income Statement Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Sales 24,248.00
25,287.00
26,669.00
30,235.00
22,170.00
22,495.00
24,172.00
26,559.00
29,819.00
27,049.00
growth rate 4.3% 5.5% 13.4% -26.7% 1.5% 7.5% 9.9% 12.3% -9.3%
Op.Income 2,531.00
4,395.00
3,928.00
3,638.00
2,731.00
2,359.00
-116.00
2,689.00
5,008.00
4,266.00
growth rate 73.7% -10.6% -7.4% -24.9% -13.6% -100.0% 100.0% 86.2% -14.8%
IBT 1,987.00
1,997.00
979.00
933.00
-624.00
1,909.00
4,486.00
4,188.00
growth rate 0.5% -51.0% -4.7% -100.0% 100.0% 135.0% -6.6%
Net Income 2,531.00
2,285.00
1,433.00
1,390.00
1,188.00
1,376.00
-967.00
1,222.00
3,239.00
2,970.00
growth rate -9.7% -37.3% -3.0% -14.5% 15.8% -100.0% 100.0% 165.1% -8.3%
EPS 10.00
9.98
9.04
5.67
5.50
4.91
5.49
-3.55
4.48
11.89
10.90
growth rate -0.2% -9.4% -37.3% -3.0% -10.7% 11.8% -100.0% 100.0% 165.4% -8.3%
Gross Profit 12,704.00
12,747.00
13,110.00
14,163.00
10,398.00
10,712.00
11,155.00
12,455.00
14,857.00
13,580.00
growth rate 0.3% 2.9% 8.0% -26.6% 3.0% 4.1% 11.7% 19.3% -8.6%
R&D 597.00
598.00
538.00
594.00
691.00
762.00
1,033.00
851.00
growth rate 0.2% -10.0% 10.4% 16.3% 10.3% 35.6% -17.6%

Quarterly Statements

Item Name Sep '21 Dec '21 Mar '22 Jun '22 Sep '22
Earnings BIT 1,092.00
979.00
798.00
912.00
1,121.00
growth rate -10.4% -18.5% 14.3% 22.9%
Balance Sheet Sep '21 Dec '21 Mar '22 Jun '22 Sep '22
Acct.Receivable 5,479.00
6,038.00
5,867.00
6,302.00
6,366.00
growth rate 10.2% -2.8% 7.4% 1.0%
Acct.Payable 1,612.00
1,921.00
1,946.00
1,964.00
1,902.00
growth rate 19.2% 1.3% 0.9% -3.2%
Cur.Assets 15,161.00
15,069.00
15,482.00
16,356.00
17,671.00
growth rate -0.6% 2.7% 5.7% 8.0%
Total Assets 43,408.00
44,555.00
45,451.00
48,480.00
51,907.00
growth rate 2.6% 2.0% 6.7% 7.1%
Cash 4,654.00
4,076.00
4,319.00
4,147.00
4,839.00
growth rate -12.4% 6.0% -4.0% 16.7%
Inventory 5,028.00
4,767.00
5,296.00
5,907.00
6,466.00
growth rate -5.2% 11.1% 11.5% 9.5%
Cur.Liabilities 1,612.00
10,610.00
1,946.00
1,964.00
2,321.00
growth rate 558.2% -81.7% 0.9% 18.2%
Liabilities 19,375.00
19,378.00
18,927.00
20,206.00
21,000.00
growth rate 0.0% -2.3% 6.8% 3.9%
LT Debt 4,516.00
2,795.00
3,197.00
4,103.00
3,790.00
growth rate -38.1% 14.4% 28.3% -7.6%
Equity 23,598.00
24,750.00
26,087.00
27,820.00
30,452.00
growth rate 4.9% 5.4% 6.6% 9.5%
Common Shares 136.00
136.00
136.00
136.00
136.00
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Sep '21 Dec '21 Mar '22 Jun '22 Sep '22
Capital Expenditures 245.00
-202.00
239.00
300.00
276.00
growth rate -100.0% 100.0% 25.5% -8.0%
Cash Dividends 24.00
1,089.00
1,089.00
1,089.00
15.00
growth rate 4,437.5% 0.0% 0.0% -98.6%
Cash From OA 1,495.00
1,570.00
647.00
424.00
1,276.00
growth rate 5.0% -58.8% -34.5% 200.9%
Sale Purchase of Stock
growth rate
FCF 1,250.00
1,368.00
408.00
124.00
1,000.00
growth rate 9.4% -70.2% -69.6% 706.5%
Income Statement Sep '21 Dec '21 Mar '22 Jun '22 Sep '22
Sales 6,306.00
7,988.00
6,182.00
6,670.00
6,941.00
growth rate 26.7% -22.6% 7.9% 4.1%
Op.Income 1,092.00
979.00
798.00
912.00
1,121.00
growth rate -10.4% -18.5% 14.3% 22.9%
IBT 1,052.00
1,076.00
749.00
866.00
1,075.00
growth rate 2.3% -30.4% 15.6% 24.1%
Net Income 757.00
772.00
534.00
603.00
798.00
growth rate 2.0% -30.8% 12.9% 32.3%
Gross Profit 3,133.00
3,940.00
3,053.00
3,149.00
3,380.00
growth rate 25.8% -22.5% 3.1% 7.3%
R&D 200.00
234.00
253.00
265.00
255.00
growth rate 17.0% 8.1% 4.7% -3.8%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (51.51)

YOY Growth Grade:

E (19.73)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

Current EPS is negative, therefore value price cannot be calculated.

PE and EPS

Historical Current Forward
PE 12.51 -32.82 34.00
EPS / Growth 25.6% -0.26 1.1%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 7.9%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.1% 4.5% 4.5%
Future PE 2.18 10.75 10.75
Future EPS 0.00 0.00 0.00
Value Price
MOS %
0.00
-100.0%
0.00
-100.0%
0.00
-100.0%
MOS Price 0.00 0.00 0.00
IRT 99.00 99.00 99.00

Graham Number:

Current EPS is negative, therefore Graham Number cannot be calculated.
NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.